1.
Paller A, Silverberg J, Hong HC ho, Cork M, Puig L, Arlert P, Kurbasic A, Soldbro L, Simpson E. The impact of tralokinumab on quality of life and school in patients aged 12-17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial. J of Skin [Internet]. 2023Mar.13 [cited 2025Jan.10];7(2):s139. Available from: https://skin.dermsquared.com/skin/article/view/2026